Cho JH

Featured in: Favicon

Articles

Are immune checkpoint inhibitors safe and effective in lung cancer patients with pre-existing interstitial lung disease?

Mar 21, 2024 | futuremedicine.com | Cho JH |Jung Ha |Lin Zhu |Rong Gao

Supplemental MaterialsMetricsHistoryReceived 16 July 2023 Accepted 26 February 2024 Published online 21 March 2024 Information© 2024 Expert Publishing Medicine Ltd trading as Taylor & FrancisKeywordsSupplementary dataTo view the supplementary data that accompany this paper, please visit the journal website at: www.futuremedicine.com/doi/suppl/10.2217/imt-2023-0147Author contributionsL Zhu and H Li conducted literature retrieval, data extraction and literature quality evaluation.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.